On July 19, 2010
Down to the Bone: Is an HIV Drug’s Link to Fractures Underplayed?
Gilead (GILD)’s HIV drug Viread already carries a warning for loss of bone density, among many others, but a rash of recent studies suggests the FDA should require its much more serious “black box” warning for potential bone fractures. Such
…
0 Comments